First isolation of bla(VIM-2) in Klebsiella oxytoca clinical isolates from Portugal.
Conceição
T
T
Brízio
A
A
Duarte
A
A
Barros
R
R
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D024881:Drug Resistance, Bacterial; D006801:Humans; D007231:Infant, Newborn; D007710:Klebsiella Infections / Q000382:microbiology*; D041121:Klebsiella oxytoca / Q000187:drug effects / Q000201:enzymology* / Q000235:genetics / Q000302:isolation & purification; D008826:Microbial Sensitivity Tests; D011174:Portugal; D001618:beta-Lactamases / Q000235:genetics / Q000302:isolation & purification* / Q000378:metabolism
D000900:Anti-Bacterial Agents; C425108:beta-lactamase bla(vim-2); D001618:beta-Lactamases